News

Fierce Biotech2d
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...
NJBIZ1d
Sanofi’s $130M Morristown flagship puts people first
Sanofi relocated 2,000 employees to a new $130M Morristown flagship office at M Station West in May, leaving Bridgewater.
3 High-Flying Stocks That Could Soar Even More
Many investors love the "big mo." That's short for "big momentum." Stocks that are on a roll often keep the good times going.
Sanofi to Invest at Least $20 Billion in US Through 2030
Sanofi SA said it will invest at least $20 billion in the US through 2030, joining other European pharmaceutical companies ...
Medical Dialogues9h
Sanofi Gets CDSCO Panel Nod to Update Aldurazyme Prescribing Information
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to ...
BioSpace1d
GSK Wins COPD Expansion for Nucala After FDA Delay
The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...
Explore more
Sanofi Redefines R&D strategy with AI: Vanguards of Health Care
Houman Ashrafian, Head of R&D at Sanofi. In this episode, Ashrafian joins Bloomberg Intelligence analyst Sam Fazeli to unpack how AI-powered portfolio construction, franchise-based innovation and a ...